EssaysForStudent.com - Free Essays, Term Papers & Book Notes
Search

Pharmacogenomics

By:   •  Research Paper  •  1,171 Words  •  December 25, 2009  •  1,195 Views

Page 1 of 5

Join now to read essay Pharmacogenomics

PHARMACOGENOMICS

INTRODUCTION

Pharmacogenomics is the study of how an individual's genetic inheritance affects the body's response to drugs. The term comes from the words pharmacology and genomics and is thus the intersection of pharmaceuticals and genetics. Pharmacogenomics holds the promise that drugs might one day be tailor-made for individuals and adapted to each person's own genetic makeup. Environment, diet, age, lifestyle, and state of health all can influence a person's response to medicines, but understanding an individual's genetic makeup is thought to be the key to creating personalized drugs with greater efficacy and safety.

Pharmacogenomics combines traditional pharmaceutical sciences such as biochemistry with annotated knowledge of genes, proteins, and single nucleotide polymorphisms.

BENEFITS OF PHARMACOGENOMICS

1- More Powerful Medicines

Pharmaceutical companies will be able to create drugs based on the proteins, enzymes, and RNA molecules associated with genes and diseases. This will facilitate drug discovery and allow drug makers to produce a therapy more targeted to specific diseases. This accuracy not only will maximize therapeutic effects but also decrease damage to nearby healthy cells.

2- Better, Safer Drugs the First Time

Instead of the standard trial-and-error method of matching patients with the right drugs, doctors will be able to analyze a patient's genetic profile and prescribe the best available drug therapy from the beginning. Not only will this take the guesswork out of finding the right drug, it will speed recovery time and increase safety as the likelihood of adverse reactions is eliminated. Pharmacogenomics has the potential to dramatically reduce the the estimated 100,000 deaths and 2 million hospitalizations that occur each year in the United States as the result of adverse drug response (1).

3- More Accurate Methods of Determining Appropriate Drug Dosages

Current methods of basing dosages on weight and age will be replaced with dosages based on a person's genetics --how well the body processes the medicine and the time it takes to metabolize it. This will maximize the therapy's value and decrease the likelihood of overdose.

4- Advanced Screening for Disease

Knowing one's genetic code will allow a person to make adequate lifestyle and environmental changes at an early age so as to avoid or lessen the severity of a genetic disease. Likewise, advance knowledge of a particular disease susceptibility will allow careful monitoring, and treatments can be introduced at the most appropriate stage to maximize their therapy.

5- Better Vaccines

Vaccines made of genetic material, either DNA or RNA, promise all the benefits of existing vaccines without all the risks. They will activate the immune system but will be unable to cause infections. They will be inexpensive, stable, easy to store, and capable of being engineered to carry several strains of a pathogen at once.

Improvements in the Drug Discovery and Approval Process

Pharmaceutical companies will be able to discover potential therapies more easily using genome targets. Previously failed drug candidates may be revived as they are matched with the niche population they serve. The drug approval process should be facilitated as trials are targeted for specific genetic population groups --providing greater degrees of success. The cost and risk of clinical trials will be reduced by targeting only those persons capable of responding to a drug.

6- Decrease in the Overall Cost of Health Care

Decreases in the number of adverse drug reactions, the number of failed drug trials, the time it takes to get a drug approved, the length of time patients are on medication, the number of medications patients must take to find an effective therapy, the effects of a disease on the body (through early detection), and an increase in the range of possible drug targets will promote a net decrease in the cost of health care.

ESSENCE OF PHARMACOGENOMICS

Pharmacogenomics is the study of the effect of polymorphisms on drug metabolism and toxic side effects of pharmaceutical agents. Oligonucleotide arrays can be used to identify presence of specific alleles in individuals, or to quantify allele ratios in populations e.g. Affymetrix CYP chip (18 known mutations defining 10 alleles of CYP2D6 and 2 alleles of CYP2C19). Microelectronic arrays can improve sensitivity/accuracy in detecting single

Continue for 4 more pages »  •  Join now to read essay Pharmacogenomics and other term papers or research documents
Download as (for upgraded members)
txt
pdf